Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Instara™-1 Dual Perspectives on Continuous Glucose Monitoring: Understanding Patient Experience and Healthcare Professional Preferences

NCT07607015 is registered in ClinicalTrials.gov with Getz Pharma as lead sponsor.

NCT NCT07607015
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07607015 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Instara™-1 Dual Perspectives on Continuous Glucose Monitoring: Understanding Patient Experience and Healthcare Professional Preferences
Lead sponsor
Getz Pharma
Phase
Observational
Overall status
Not yet recruiting
Start date
September 10, 2026
Completion date
August 10, 2027
Enrollment
75 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

diabete mellitus, gestational diabetes, pre diabetes, type1diabetes, type2diabetes